Quarterly report pursuant to Section 13 or 15(d)

Organization and Summary of Significant Accounting Policies (Tables)

v3.22.2.2
Organization and Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Error Corrections and Prior Period Adjustments
June 30, 2022 December 31, 2021
Condensed Consolidated Balance Sheets As Previously Reported Restatement Adjustment As Restated As Previously Reported Restatement Adjustment As Restated
Deferred revenue 37,576  31,595  69,171  43,345  19,094  62,439 
Total current liabilities 230,101  31,595  261,696  133,958  19,094  153,052 
Total liabilities 235,940  31,595  267,535  276,436  19,094  295,530 
Accumulated deficit (1,462,108) (31,595) (1,493,703) (1,162,040) (19,094) (1,181,134)
Total stockholders' equity 95,379  (31,595) 63,784  320,825  (19,094) 301,731 
Three Months Ended June 30, 2022 Three Months Ended June 30, 2021
Condensed Consolidated Statements of Operations As Previously Reported Restatement Adjustment Restated As Previously Reported Restatement Adjustment Restated
Revenues:
Sharing 72,395  (9,897) 62,498  56,638  (4,390) 52,248 
Total revenues 76,662  (9,897) 66,765  60,044  (4,390) 55,654 
Cost of revenues:
Cost of sharing, exclusive of depreciation 34,086  —  34,086  29,331  1,200  30,531 
Total cost of revenues 90,007  —  90,007  44,305  1,200  45,505 
Gross margin:
Sharing 19,885  (9,897) 9,988  15,766  (5,590) 10,176 
Total gross margin (13,345) (9,897) (23,242) 15,739  (5,590) 10,149 
Loss from operations (331,243) (9,897) (341,140) (26,000) (5,590) (31,590)
Loss before income taxes (310,335) (9,897) (320,232) (43,576) (5,590) (49,166)
Net loss (310,419) (9,897) (320,316) (43,686) (5,590) (49,276)
Loss per share attributable to common stockholders, basic and diluted (1.14) (0.04) (1.18) (1.01) (0.11) (1.12)
Six Months Ended June 30, 2022 Six Months Ended June 30, 2021
Condensed Consolidated Statements of Operations As Previously Reported Restatement Adjustment Restated As Previously Reported Restatement Adjustment Restated
Revenues:
Sharing 105,972  (12,501) 93,471  78,287  (5,813) 72,474 
Total revenues 114,640  (12,501) 102,139  85,714  (5,813) 79,901 
Cost of revenues:
Cost of sharing, exclusive of depreciation 55,472  —  55,472  43,729  1,200  44,929 
Total cost of revenues 124,562  —  124,562  67,935  1,200  69,135 
Gross margin:
Sharing 23,136  (12,501) 10,635  18,000  (7,013) 10,987 
Total gross margin (9,922) (12,501) (22,423) 17,779  (7,013) 10,766 
General and administrative 169,043  —  169,043  61,955  (811) 61,144 
Total operating expenses 418,112  —  418,112  82,735  (811) 81,924 
Loss from operations (428,034) (12,501) (440,535) (64,956) (6,202) (71,158)
Loss before income taxes (299,947) (12,501) (312,448) (119,756) (6,202) (125,958)
Net loss (300,068) (12,501) (312,569) (119,886) (6,202) (126,088)
Loss per share attributable to common stockholders, basic and diluted (1.11) (0.04) (1.15) (2.67) (0.12) (2.79)
Three Months Ended June 30, 2022 Three Months Ended June 30, 2021
Consolidated Statements of Comprehensive Loss As Previously Reported Restatement Adjustment Restated As Previously Reported Restatement Adjustment Restated
Net loss (310,419) (9,897) (320,316) (43,686) (5,590) (49,276)
Total comprehensive loss, net of tax (321,982) (9,897) (331,879) (42,951) (5,590) (48,541)
Six Months Ended June 30, 2022 Six Months Ended June 30, 2021
Consolidated Statements of Comprehensive Loss As Previously Reported Restatement Adjustment Restated As Previously Reported Restatement Adjustment Restated
Net loss (300,068) (12,501) (312,569) (119,886) (6,202) (126,088)
Total comprehensive loss, net of tax (316,104) (12,501) (328,605) (121,476) (6,202) (127,678)
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit Three Months Ended June 30, 2022 Three Months Ended June 30, 2021
As Previously Reported Restatement Adjustment Restated As Previously Reported Restatement Adjustment Restated
Net loss (310,419) (9,897) (320,316) (43,686) (5,590) (49,276)
Accumulated other comprehensive income (loss) (8,498) —  (8,498) 11,415  (3,312) 8,103 
Accumulated deficit (1,462,108) (31,595) (1,493,703) (1,085,593) (6,705) (1,092,298)
Total stockholders' equity 95,379  (31,595) 63,784  (986,661) (10,017) (996,678)
Six Months Ended June 30, 2022 Six Months Ended June 30, 2021
Condensed Consolidated Statements of Cash Flow As Previously Reported Restatement Adjustment Restated As Previously Reported Restatement Adjustment Restated
Cash flows from operating activities
Net loss (300,068) (12,501) (312,569) (119,886) (6,202) (126,088)
Changes in assets and liabilities:
Deferred revenue (6,395) 12,501  6,106  1,674  5,813  7,487 
Accrued expenses and other current liabilities 9,703  —  9,703  8,342  389  8,731 
Net cash used in operating activities (47,141) —  (47,141) (45,599) —  (45,599)